Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation
EuroIntervention · 2025-05 · 21 (10) · 525-535
DOI: 10.4244/eij-d-24-00972 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EuroIntervention, 2025-05. Verfasst von Sunny Goel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve, Aortic Valve Stenosis, Coronary Occlusion. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Coronary obstruction is a rare but serious complication during transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, which is associated with high mortality. This review explores various leaflet modification techniques designed to mitigate this risk. Among the most studied methods is Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA), which uses transcatheter electrosurgery to lacerate the aortic valve leaflet and maintain coronary perfusion. Other promising techniques include ShortCut, a mechanical leaflet splitting device, and Undermining Iatrogenic Coronary Obstruction with Radiofrequency Needle (UNICORN), which utilises radiofrequency energy to achieve leaflet laceration. These approaches differ in their procedural complexity, equipment requirements, and clinical outcomes. Each technique's efficacy in preventing coronary obstruction is discussed, alongside the potential complications and the procedural challenges encountered in both native aortic valve and valve-in-valve settings. This review also highlights the importance of careful patient selection, advanced imaging techniques, and the need for further research to optimise these strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cardiology, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Division of Cardiology, Mount Sinai South Nassau, Oceanside, NY, USA.
- Department of Cardiology, Mater Private Network, Cork, Ireland.
- Cardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
- St. Francis Hospital and Heart Center, Roslyn, NY, USA.
- Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA.
Zitieren
APA
Goel, S., Tanner, R., Chan, K. E., Khan, J. M., Vinayak, M., Lerakis, S., Safi, L. M., Khera, S., Krishnamoorthy, P., Kini, A. S., Sharma, S. K., Dangas, G. D., & Tang, G. H. L. (2025). Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation. EuroIntervention, 21(10), 525-535. https://doi.org/10.4244/eij-d-24-00972
Vancouver
Goel S, Tanner R, Chan KE, Khan JM, Vinayak M, Lerakis S, et al. Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation. EuroIntervention. 2025;21(10):525-535. doi:10.4244/eij-d-24-00972
BibTeX
@article{Goel2025,
author = {Goel, Sunny and Tanner, Richard and Chan, Kwong-Yue Eric and Khan, Jaffar M and Vinayak, Manish and Lerakis, Stamatios and Safi, Lucy M and Khera, Sahil and Krishnamoorthy, Parasuram and Kini, Annapoorna S and Sharma, Samin K and Dangas, George D and Tang, Gilbert H L},
title = {Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation},
journal = {EuroIntervention},
year = {2025},
volume = {21},
number = {10},
pages = {525--535},
doi = {10.4244/eij-d-24-00972}
}
EUVIMED